Chemomab Therapeutics Ltd.

CMMB | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.38

-$0.10 (-4.03%)

At close: Sep 22, 2026, 4:00 PM ET

$2.49

+$0.11 (+4.62%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $15.26M

Enterprise Value $8.58M

Beta 0.66

Average Volume 118.78K

Shares Outstanding (Diluted) 8M

Shares Change YoY 38.13%

Institutional Ownership 4.41%

Exchange NASDAQ

ISIN US16385C2035

Price Performance

Price Change 1M 13.2%

Price Change 3M 65.3%

Price Change 6M 56.0%

Price Change YTD 38.5%

Price Change 1Y -5.7%

Price Change 3Y -32.6%

Price Change 5Y -94.8%

1M CAGR (ann.) 28.5%

1Y CAGR (ann.) -5.7%

5Y CAGR (ann.) -46.5%

All-Time CAGR -52.3%

Valuation

PE Ratio -2.43

Forward PE N/A

PEG Ratio -0.02

Forward PEG -0.05

PS Ratio N/A

Forward PS 0.40

PB Ratio 1.76

P/FCF Ratio -1.36

P/Adj. FCF Ratio -1.36

P/OCF Ratio -1.77

EV/Sales N/A

EV/EBIT -1.08

EV/EBITDA -1.08

EV/FCF -0.76

Earnings Yield -41.1%

FCF Yield -73.5%

Adj. FCF Yield -73.5%

Financial Health

Net Cash $6.69M

Total Debt $0

Cash & Short-Term Investments $6.69M

Total Assets $10.24M

Current Ratio 6.41

Quick Ratio 6.41

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score -11.48

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets -74.3%

Return on Equity -70.8%

Return on Invested Capital -91.7%

Return on Capital Employed -91.7%

Return on Tangible Assets -74.3%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 67.0%

EPS CAGR 5Y 39.3%

EPS CAGR 10Y 37.1%

FCF CAGR 3Y 28.3%

FCF CAGR 5Y 23.7%

FCF CAGR 10Y -7.5%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y 32.0%

Revenue Growth Next 3Y N/A

Earnings Date Nov 5, 2026

EPS Estimate (next Q) -$0.01

EPS Growth Est (next Q) -37.5%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-11.22M

Free Cash Flow $-11.22M

Adj. Free Cash Flow $-11.22M

FCF Per Share -$1.40

OCF Per Share -$1.40

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-7.96M

EBITDA $-7.92M

Net Income $-7.6M

EPS (Diluted) -$1.02

Revenue / Employee N/A

Profit / Employee $-633.49K

Employees 12